Cancer patient pathways shortens waiting times and accelerates the diagnostic process of suspected sarcoma patients in Denmark

Health Policy

Volumn 113, Issue 1-2, 2013, Pages 110-117

  Dyrop, Heidi Buvarp ^a   Safwat, Akmal ^a   Vedsted, Peter ^b   Maretty Nielsen, Katja ^a   Hansen, Bjarne Hauge ^a   Jørgensen, Peter Holmberg ^a   Baad Hansen, Thomas ^a   Bünger, Cody ^a   Keller, Johnny ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Cancer Patient Pathway; Denmark; Early cancer diagnosis; Neoplasm; Sarcoma

Indexed keywords

ADULT; ARTICLE; AWARENESS; BONE TUMOR; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PATIENT PATHWAY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOMA; DENMARK; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE MYELOMA; OSTEOSARCOMA; PATIENT REFERRAL; SARCOMA; SOFT TISSUE SARCOMA; TUMOR VOLUME;

CANCER PATIENT PATHWAY; DENMARK; EARLY CANCER DIAGNOSIS; NEOPLASM; SARCOMA;

ADULT; AGED; CRITICAL PATHWAYS; DENMARK; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; SARCOMA; TIME FACTORS; WAITING LISTS;

EID: 84887614653     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2013.09.012     Document Type: Article

References (24)

1. Nielsen O.S., Keller J.O., Dombernowsky P. Sarcomas. Ugeskrift for Laeger 2002, 164:3036-3039.
2. Skubitz K.M., D'Adamo D.R. Sarcoma. Mayo Clinic Proceedings 2007, 82:1409-1432.
3. Clasby R., Tilling K., Smith M.A., Fletcher C.D. Variable management of soft tissue sarcoma: regional audit with implications for specialist care. British Journal of Surgery 1997, 84:1692-1696.
4. Grimer R.J., Briggs T.W. Earlier diagnosis of bone and soft-tissue tumours. Journal of Bone and Joint Surgery. British Volume 2010, 92:1489-1492.
5. Neal R.D. Do diagnostic delays in cancer matter?. British Journal of Cancer 2009, 101(Suppl. 2):S9-S12.
6. Torring M.L., Frydenberg M., Hansen R.P., Olesen F., Hamilton W., Vedsted P. Time to diagnosis and mortality in colorectal cancer: a cohort study in primary care. British Journal of Cancer 2011, 104:934-940.
7. Maringe C., Walters S., Butler J., Coleman M.P., Hacker N., Hanna L. Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecologic Oncology 2012, 127:75-82.
8. Wang J., Mahasittiwat P., Wong K.K., Quint L.E., Kong F.M. Natural growth and disease progression of non-small cell lung cancer evaluated with (18)F-fluorodeoxyglucose PET/CT. Lung Cancer 2012, 78:51-56.
9. Saithna A., Pynsent P.B., Grimer R.J. Retrospective analysis of the impact of symptom duration on prognosis in soft tissue sarcoma. International Orthopaedics 2008, 32:381-384.
10. Nakamura T., Matsumine A., Matsubara T., Asanuma K., Uchida A., Sudo A. The symptom-to-diagnosis delay in soft tissue sarcoma influence the overall survival and the development of distant metastasis. Journal of Surgical Oncology 2011, 104:771-775.
11. Rougraff B.T., Davis K., Lawrence J. Does length of symptoms before diagnosis of sarcoma affect patient survival?. Clinical Orthopaedics and Related Research 2007, 462:181-189.
12. Pencavel T.D., Strauss D.C., Thomas G.P., Thomas J.M., Hayes A.J. Does the two-week rule pathway improve the diagnosis of soft tissue sarcoma?. A retrospective review of referral patterns and outcomes over five years in a regional sarcoma centre. Annals of the Royal College of Surgeons of England 2010, 92:417-421.
13. Prades J., Espinas J.A., Font R., Argimon J.M., Borràs J.M. Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods study. British Journal of Cancer 2011, 105:753-759.
14. Jansen-Landheer M.L., Krijnen P., Oostindier M.J., Kloosterman-Boele W.M., Noordijk E.M., Nooij M.A. Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: a population-based study. European Journal of Surgical Oncology 2009, 35:1326-1332.
15. Nijhuis P.H., Schaapveld M., Otter R., Hoekstra H.J. Soft tissue sarcoma-compliance with guidelines. Cancer 2001, 91:2186-2195.
16. Olesen F., Hansen R.P., Vedsted P. Delay in diagnosis: the experience in Denmark. British Journal of Cancer 2009, 101(Suppl. 2):S5-S8.
17. Probst H.B., Hussain Z.B., Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians-a national Danish project. Health Policy 2012, 105:65-70.
18. Weller D., Vedsted P., Rubin G., Walter F.M., Emery J., Scott S., et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. British Journal of Cancer 2012, 106:1262-1267.
19. Clark M.A., Thomas J.M. Delay in referral to a specialist soft-tissue sarcoma unit. European Journal of Surgical Oncology 2005, 31:443-448.
20. Johnson G.D., Smith G., Dramis A., Grimer R.J. Delays in referral of soft tissue sarcomas. Sarcoma 2008, 2008:378574.
21. Malik A., Wigney L., Murray S., Gerrand C.H. The effectiveness of "two-week" referrals for suspected bone and soft tissue sarcoma. Sarcoma 2007, 23870.
22. Rydholm A. Improving the management of soft tissue sarcoma. Diagnosis and treatment should be given in specialist centres. BMJ 1998, 317:93-94.
23. Styring E., Billing V., Hartman L., Nilbert M., Seinen J.M., Veurink N., et al. Simple guidelines for efficient referral of soft-tissue sarcomas: a population-based evaluation of adherence to guidelines and referral patterns. Journal of Bone and Joint Surgery 2012, 94:1291-1296.
24. Grimer R.J. Size matters for sarcomas!. Annals of The Royal College of Surgeons of England 2006, 88:519-524.